Prediction: Pfizer Stock Could Double If Pipeline Delivers
Pfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
Recovering from budget neglect requires a clear plan: rebuild essential budgets, tackle debt strategically, and track progress weekly.
28,655 articlesPfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
Fresh inflows into ripple (xrp) funds continue despite a broad downturn in crypto ETFs. XRP price remains around $1.1...
A June 17 memorandum between the U.S. and Iran aims to reopen key chokepoints and ease energy markets. Analysts say r...
Oil trades near the mid-$70s on June 24, 2026, as supply concerns and demand signals shape the price outlook for cons...
In a volatile year, personal-finance experts advocate patience over rash bets. The uncertainty paradox: believe not, ...
Trump granted clemency to 11 people on a Friday ahead of July 4, spotlighting emissions-related cases and a partner o...
Micron stock retreats after a spring rally, renewing the debate over whether the memory chip maker has peaked. Analys...
Bitcoin faces a steep uphill climb after last year’s peak left early buyers in the red. Analysts say a near 90% rally...
Lucid Group delivered a stronger top line in Q4, but cash burn remains a key hurdle. Investors will parse the mix of ...
Bitcoin climbs above $71,000, fueling a premarket lift in crypto-linked stocks. Coinbase and Circle lead gains as inv...
XRP/BTC is flashing a major warning as the pair struggles under key moving averages and tests vital support, keeping ...
Bitcoin faced a key test near $74,000 as geopolitical tensions intensified, and BlackRock launched its ETHB ETF, resh...